RenovoRx, Inc. - Common Stock — Cash Flow (NASDAQ:RNXT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -5.92 M-8.81 M-10.26 M-9.13 M-10.97 M -11.3 M Cash from investing activities -15 K-2.03 M2.03 M-12 K-2 000 0 Cash from financing activities 19.33 M42 K5.01 M15.12 M10.85 M 9.08 M Free cash flow -5.92 M-8.81 M-10.26 M-9.13 M-10.97 M -11.3 M

News

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Tops Revenue Estimates

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates

Cytokinetics (CYTK) Reports Q1 Loss, Beats Revenue Estimates

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q4 Loss, Misses Revenue Estimates

Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates

Jones Trading initiates coverage on RenovoRx stock with Buy rating

Agah Ramtin, chief medical officer at RenovoRx, buys $9975 in shares

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)